Icon
+91 94997 68112
Login Register

Vemlidy - (25 mg; Tablet, Oral)

Tenofovir Alafenamide Fumarate Gilead
25 mg; Tablet, Oral
Less Than $1000 mn
More Than 5
More Than 5
More Than 5
Less Than 5
Less Than 5
 None
VEMLIDY is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 12 years of age and older with compensated liver disease.
Yes
*** *********** ******* ** *** *, **** ******, ******, ****** ****, *****, ****** ********, ******** ****** *** ****. ***** ***** * **** ** ** *** ******* *** *** *********. ******, ******, ****** ****, ****** ********, ******** ****** ***** * **** ** ** ******* '***, '*** *** **** *********. ** ***** **** **** **** ****** ** *** ****. ********* ** *** ****** ** ******, ******** ****** ****** ** ****.
Vemlidy Patent 1 Patent 2 Patent 3 Patent 4
****** **** *** ******* ******* *******
****** ******* ******* ******* *******
****** **** ********* ** **** *** ******* ****** **** *** ********** ********* ** **** *** ********* ** **** ***
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ********* *** *, **** ******* ******** ** *** **, ****
****** *** \ ********* *** *, **** ******* **** ** *** **, ****
****** **** *** \ ** *** *, **** ********* ** **** *** ********* ******** ***** *** ****
  1. *** **, **** : ****** ******** ****** ***** **'* **** ** ****** ** ******* '*** *** '***.
  2. *** *, **** : ***** ******** ****** ***** **'* **** ** ****** ** ******* '***, '***, '***, '***
  3. *** *, **** : ****** ******** *** ******** ****** ******** ****** ***** **'* **** ** ****** ** ******* '*** *** '***.
  4. *** *, **** : ****** **** ******** ****** ***** **'* **** ** ****** ** ******* '*** *** '***.
  5. *** **, **** : ****** ******** ****** ***** **'* **** ** ****** ** ******* '*** *** '***.
  6. *** *, **** : ****** ***** * **** ******* ******, ****** ****, ****** ********, ******** ****** *** ****** ** ******* '***, '***
  7. *** *, **** : ****** ***** * **** ******* ***** ** ******* ***, '***, '***, '***
  8. *** **, **** : ***** ******* ** ****** **** ** ************* ** ****** '***
  9. *** **, **** : ****** ***** * **** ******* ***** , ****** ****, ****** ********, ******** ******,*** ****** ** ****** '*** '*** '*** *** '***
  10. *** **, **** : ****** ******* **** * ********** ********* **** ****** ** ******* ***** ** **********.
  11. *** **, **** : ****** ******* **** ******** ***** ******* *****.
  12. *** **, **** : ****** ********* *** **** ** ************** ** **** ***.
  13. *** *, **** : ****** ******* ********** **** ****** *** *****.
  14. *** **, **** : ****** ******* ********** **** ******.
  15. *** **, **** : ********* ** ********** ********* ***** ** ******'* *** ******, *** ******** *** ****** ** *** **, ****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.